News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

Cardioneural ablation provides a new treatment option for vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Experts raise concern about high cost-sharing for imaging in some Medicare Advantage plans

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology.

cybersecurity cyberattack hack hackers lock protection

Homeland Security warns of vulnerabilities in medical imaging software

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers.

University opens $30M new research imaging center focused on liver disease

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments.

PwC predicts: Providers, payers, pharma, medtech—all will have new to-do lists after the midterm elections. And that’s regardless of results.

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in?

Reimbursement expected to drive implementation of CCTA, coronary plaque analysis

For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.

Vesalio enVast coronary mechanical thrombectomy system gained FDA in December 2025.

FDA clears new stent-based coronary thrombectomy system

The newly cleared system offers clinicians a new option for capturing and removing large coronary thrombi in patients undergoing primary PCI.

Targeting women eligible for both lung and breast cancer screening pays off

“There is enormous potential here, and the [American Cancer Society] is thrilled with the outcome of this study," one investigators says.

Radiology provider Lumexa Imaging unveils pricing of IPO

The Raleigh, North Carolina-based company—which formerly went by US Radiology Specialists—is offering 25 million shares of common stock at $18.50 apiece.

Around the web

Cardiovascular Business

FDA clears AI-enabled CCTA plaque analysis tool from Keya Medical

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Cardiovascular Business

Cardiologists highlight early success with leaflet modification device for valve-in-valve TAVR

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

Cardiovascular Business

American College of Cardiology celebrates 100 hospitals for offering ‘highest level of cardiovascular care’

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?